| Purity | Size | Price(USD) | Lead Time | Quantity |
|---|---|---|---|---|
| 95% | 100mg | 200.0 | 1~3 weeks | |
| 95% | 250mg | 290.0 | 1~3 weeks | |
| 95% | 500mg | 574.0 | 1~3 weeks | |
| 95% | 1g | 750.0 | 1~3 weeks | |
| 95% | 2.5g | 1363.0 | 1~3 weeks | |
| 95% | 5g | 2110.0 | 1~3 weeks | |
| 95% | 10g | 3120.0 | 1~3 weeks |
| Cat. No. | M227207 | CAS No. | 1094219-66-5 |
| Chemical Name | 4-Oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepine-7-carboxylic acid | MDL No. | |
| Molecular Weight | 206.20 | Molecular Formula | C10H10N2O3 |
| Boiling Point | Storage | ||
| Description | 4-Oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepine-7-carboxylic acid is a compound of Heterocyclic Building Blocks research chemicals for sale. Its CAS No. is 1094219-66-5, molecular formula is C10H10N2O3 and its molecular weight is 206.20 g/mol. The purity is usually 95%. Moldb provide CAS No.1094219-66-5, 4-Oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepine-7-carboxylic acid, 95% and document regarding 4-Oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepine-7-carboxylic acid, C10H10N2O3, including NMR, HPLC, LC-MS and more. | ||
| Signal Word: | UN# | ||
| GHS Pictogram | Class | ||
| Hazard Statements | Packing Group | ||
| Precautionary Statements | |||
* For research and development use only. Not for human or other use.
